| Literature DB >> 34818406 |
Jacobo Giner1,2, Sergio Villanueva-Saz1,2,3, Antonio Fernández1,2,3, María Asunción Gómez4, Madis Podra4, Patricia Lizarraga5, Delia Lacasta1,3, Héctor Ruiz1, María Del Carmen Aranda6, María de Los Ángeles Jimenez7, Raquel Hernández8, Andrés Yzuel2, Maite Verde1,2,3.
Abstract
The European mink (Mustela lutreola) is listed as a critically endangered species because of ongoing population reduction from habitat degradation and the effects of introduced species, such as American mink (Neovison vison). This small, fragmented population becomes vulnerable to many other threats, including diseases. Leishmaniosis is a zoonotic disease caused by the protozoan parasite Leishmania infantum found in the Mediterranean area, which affects many mammals, including wild small mammals. Furthermore, clinical disease caused by L. infantum has recently been described in other mustelids. To assess the exposure to Leishmania sp. infection in mink species in northern Spain, blood samples from 139 feral American mink and 42 native European mink from north Spain were evaluated for Leishmania sp. infection using enzyme-linked immunosorbent assays against Leishmania spp. antibodies, with 52.4% of American mink and 45.3% of European mink being found seropositive. This finding raises questions regarding how the disease may affect these species and the potential repercussions for conservation efforts. Despite a high seroprevalence being observed in wild mink of both species in this study, association with clinical or pathologic signs of disease has yet to be elucidated. © Wildlife Disease Association 2022.Entities:
Keywords: zzm321990 Leishmania infantumzzm321990 ; serologic survey; wild minks
Mesh:
Year: 2022 PMID: 34818406 DOI: 10.7589/JWD-D-21-00027
Source DB: PubMed Journal: J Wildl Dis ISSN: 0090-3558 Impact factor: 1.535